Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-11

Clinical Trial Update: Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial update evaluating the safety and efficacy of a dendritic cell vaccine in combination with temozolomide for newly diagnosed glioblastoma after su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DC Vaccine
  • Temozolomide (Temozolomide)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Glioblastoma Multiforme of Brain | Phase 1 | Status: ACTIVE_NOT_RECRUITING